Nurse Practitioner Program year 2025 Reported 2021–2025 Source: CMS Open Payments, 2026 publication

Jennifer Dole

Clinical Nurse Specialist, Critical Care Medicine Kankakee, IL Nurse Practitioner

NPI 1376892398 CMS profile 11206026

500 N Wall St Ste C100, Kankakee, IL 60901

Open in the dashboard

General payments

$2,921

110 records reported · program years 2021–2025

Research payments

$0

Paid to them · None reported · program years 2021–2025

Ownership & investment interest

$0

None reported

Through program year 2025, Jennifer Dole of Kankakee, IL is reported in the CMS Open Payments database as having received $2,921 across 110 general payments and $0 in research payments paid to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 90th percentile of Clinical Nurse Specialist, Critical Care Medicine profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

5 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $709 10
2024 General $15 1
2023 General $244 14
2022 General $1,100 34
2021 General $853 51

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Jennifer Dole
  • Clinical Nurse Specialist, Critical Care Medicine median
  • Middle half of Clinical Nurse Specialist, Critical Care Medicine
  • National median

In program year 2025, general payments to Jennifer Dole were reported at $709. Among 64 Clinical Nurse Specialist, Critical Care Medicine profiles paid that year, the median was $203 and the middle half received between $69 and $463.

Show as a table
Year Jennifer Dole Clinical Nurse Specialist, Critical Care Medicine median Middle half National median
2019 $0 — — $163
2020 $0 — — $114
2021 $853 $116 $52–$319 $132
2022 $1,100 $163 $44–$271 $149
2023 $244 $180 $66–$328 $160
2024 $15 $150 $50–$433 $164
2025 $709 $203 $69–$463 $169

Breakdown

Who paid General payments · program years 2021–2025
  1. Atricure, Inc. $665 8 payments
  2. Preventric Diagnostics, Inc. $540 1 payment
  3. Amgen Inc. $259 15 payments
  4. AstraZeneca Pharmaceuticals LP $258 14 payments
  5. Janssen Pharmaceuticals, Inc $156 9 payments
  6. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $145 10 payments
  7. Bayer HealthCare Pharmaceuticals Inc. $103 7 payments
  8. Merck Sharp & Dohme Corporation $98 6 payments
  9. Lantheus Medical Imaging, Inc. $98 5 payments
  10. Alnylam Pharmaceuticals Inc. $93 5 payments
  11. Other $506 30 payments

Every payment, record by record

What the payments were for General payments · program years 2021–2025
  1. Food and Beverage $2,648 108 payments
  2. Travel and Lodging $273 2 payments
Products named General payments · program years 2021–2025
  1. EPI-SENSE GUIDED COAGULATION SYSTEM WITH VISITRAX $665 8 payments
  2. SYNERGY ABLATION SYSTEM $611 7 payments
  3. BPRO BT AMBULATORY BLOOD PRESSURE MONITORING SYSTEM $540 1 payment
  4. Repatha $259 15 payments
  5. FARXIGA $203 11 payments
  6. XARELTO $156 9 payments
  7. LifeVest $145 10 payments
  8. VERQUVO $98 6 payments
  9. DEFINITY $98 5 payments
  10. GORE CARDIOFORM Septal Occluder $84 4 payments
  11. Other $969 57 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Prescribing to Medicare patients

Part D · data year 2024 · 5 drugs

Part D claims

107

Median for Certified Clinical Nurse Specialist: 344

Drug cost

$486

Median for Certified Clinical Nurse Specialist: $20,739

Branded share of claims

16.8%

Median for Certified Clinical Nurse Specialist: 20.5%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Amiodarone Hcl Generic 20 $184
Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen Brand 18 $131
Atorvastatin Calcium Generic 16 $68
Metoprolol Tartrate Generic 28 $61
Furosemide Generic 25 $41

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 1,644 Part D prescribers listed as Certified Clinical Nurse Specialist; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 6 billing codes

Paid by Medicare

$9,289

Medicare's payments for the services billed

Medicare patients

59

Average age 75

Services billed

90

21 women, 38 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Ischemic heart disease 75%
Heart failure 66%
Arthritis 63%
Atrial fibrillation 54%
Chronic kidney disease 51%
Diabetes 46%
COPD 46%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Records

110 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Nurse Specialist, Critical Care Medicine in Illinois

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record